p-Index From 2021 - 2026
11.301
P-Index
This Author published in this journals
All Journal HAYATI Journal of Biosciences Journal of Food and Pharmaceutical Science Indonesian Journal of Biotechnology MPI (Media Pharmaceutica Indonesiana) The Indonesian Biomedical Journal Science and Technology Indonesia Jurnal Akta Jurnal Fitofarmaka Indonesia DUNAMIS: Jurnal Teologi dan Pendidikan Kristiani Jurnal Pro Hukum : Jurnal Penelitian Bidang Hukum Universitas Gresik JFIOnline Jurnal Ilmu Kefarmasian Indonesia Jurnal Jamu Indonesia Journal of Social Science Jurnal Health Sains JURNAL RECTUM: Tinjauan Yuridis Penanganan Tindak Pidana Devotion: Journal of Research and Community Service Narra J International Journal of Social Service and Research Jurnal Impresi Indonesia International Journal of Science and Society (IJSOC) Indonesian Journal of Multidisciplinary Science Journal of Social Research Journal Of World Science MEDICINUS Journal of Law, Poliitic and Humanities Journal of Social Science The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy Return : Study of Management, Economic and Bussines INJURITY: Journal of Interdisciplinary Studies Journal Research of Social Science, Economics, and Management Eduvest - Journal of Universal Studies Jurnal Ekonomi, Teknologi dan Bisnis Journal of Social Science Influence: International Journal of Science Review Al Makki Health Informatics Journal Journal of Food and Pharmaceutical Sciences Journal of Law and Social Politics Asian Journal of Social and Humanities Indonesian Journal of Jamu Glosains: Jurnal Sains Global Indonesia
Claim Missing Document
Check
Articles

Beyond Black-Letter Antitrust: Pharmaceutical Patent Expiry, GenericCompetition, and the Rule of Reason in the Pfizer-Dexa Amlodipine Case a Comparative Legal-Systemic Study of Indonesia, the United States, the European Union, and Japan Raymond R. Tjandrawinata
Asian Journal of Social and Humanities Vol. 4 No. 9 (2026): Asian Journal of Social and Humanities
Publisher : Pelopor Publikasi Akademika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59888/ajosh.v4i9.747

Abstract

This article examines the Pfizer-Dexa amlodipine case as a critical point of intersection among pharmaceutical patent law, generic competition, market regulation, and antitrust adjudication. Rather than treating the case merely as a failed cartel prosecution, the article argues that it reveals a deeper methodological problem in pharmaceutical competition law: the risk of interpreting high prices and parallel market behavior as evidence of collusion without conducting a sufficiently systemic economic and legal inquiry. Using Indonesia as the primary case study and comparing it with the United States, the European Union, and Japan, the article develops the concept of a pharmaceutical systemic rule of reason. This framework requires competition authorities and courts to assess patent expiry, drug approval, generic entry, branded generics, prescription dynamics, distribution structures, and patient access as interconnected components of a regulated health market. The article contributes to antitrust theory by demonstrating that pharmaceutical competition cannot be reduced either to patent absolutism or anti-cartel formalism. Instead, it must be evaluated as a living system in which innovation, access, evidentiary rigor, and market fairness are held together.
The Structured Innovation System: Optimizing Patent Filing and Obtaining Global Protection Raymond R. Tjandrawinata; Henry Soelistyo Budi
Journal of World Science Vol. 4 No. 3 (2025): Journal of World Science
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/jws.v4i3.1373

Abstract

Intellectual property (IP) is a key component of the global economy, and it is also a critical component of ensuring global competitiveness. It is essential for organizations and inventors seeking robust global intellectual property protection to maintain competitive advantage. This study examines the role of structured innovation in enhancing patent approval rates, mitigating legal risks, and accelerating market entry for technological innovations. The study employs a mixed-methods approach, integrating legal analysis, case study evaluations, empirical data collection, and AI-based predictive modeling to provide an in-depth understanding of the factors contributing to successful patent filings and long-term intellectual property sustainability. The research also examines emerging trends in artificial intelligence and predictive analytics that are reshaping the landscape of IP management. The findings derived from this study serve as a valuable resource for policymakers, legal practitioners, and industry stakeholders seeking to enhance their innovation strategies in an increasingly competitive and complex intellectual property landscape. Specifically, this study aims to provide a strategic roadmap for optimizing patent filing and securing global protection by evaluating real-world applications and examining cross-jurisdictional intellectual property frameworks. A comparative study of patent laws across key jurisdictions, including the United States, the European Union, and China, highlights critical differences in examination procedures, enforceability, and litigation risks, providing comparative insights essential for businesses operating in global markets. The empirical findings underscore that structured innovation methodologies contribute to higher patent success rates and reduce legal uncertainties, enforcement complexities, and post-grant challenges.
From Lowest Unit Price to Lowest Total Supply Risk: A System Shift Framework for Resilience in the Global Generic Pharmaceutical Industry Raymond R. Tjandrawinata
Journal of World Science Vol. 5 No. 6 (2026): Journal of World Science
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/jws.v5i6.1676

Abstract

Generic medicines are routinely framed as a success of price competition, yet recent evidence suggests that the same competitive architecture which lowers unit prices may also weaken supply resilience. Drug shortages, approved-but-unlaunched generics, geographically concentrated active pharmaceutical ingredient (API) production, sterile-injectable vulnerabilities, and the rising technical complexity of biosimilars indicate that the global generic pharmaceutical industry is undergoing a deeper system transition. This article developed a System Shift framework to analyse these structural challenges, linking seven analytical factors: system condition, domain lock, actors, chokepoints, position, strategy, and feedback. Using a public-source qualitative comparative case analysis of twenty companies across global, Indian, European, North American, Chinese, Korean, South African, and Southeast Asian contexts, the paper identifies recurring patterns of vulnerability and strategic adaptation. The analysis shows that generic firms are not a homogeneous low-margin group; they include global off-patent platforms, vertically integrated Indian exporters, sterile-injectable specialists, biosimilar platforms, regional branded-generic leaders, and national manufacturers. Across these archetypes, the dominant feedback signal remains lowest unit price, while quality maturity, supplier redundancy, and launch reliability remain weakly rewarded. The central conclusion is that generic pharmaceutical governance must shift from a cheapest-unit paradigm toward a lowest-total-supply-risk paradigm. Procurement, regulation, and corporate strategy must incorporate multi-award tendering, explicit supply-security criteria, accelerated regulatory variation pathways, resilient API sourcing, and transparent shortage-prevention feedback loops. The paper contributes a conceptual and policy framework for reinterpreting generic medicines as resilience infrastructure rather than merely low-cost therapeutic substitutes.
System Shift Risk, Publication Effects, and the Decay of Stock Return Predictability: An Exploratory Empirical Framework Raymond Rubianto Tjandrawinata
Return : Study of Management, Economic and Bussines Vol. 5 No. 6 (2026): Return: Study of Management, Economic and Business
Publisher : PT. Publikasiku Academic Solution

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.57096/return.v5i6.479

Abstract

The decay of stock return predictability after publication has been well documented, yet the underlying mechanisms are often explained as either statistical overfitting or market efficiency. This study introduces the System Shift Finance framework as a diagnostic lens to interpret why return predictability decays when a signal moves from private discovery into a public, crowded, and adaptive market environment. The framework codes seven system variables (System Condition, Domain Lock, Actor Complexity, Chokepoint Severity, Position Quality, Strategy Quality, and Feedback Maturity) and computes a System Shift Risk Score as the sum of pressure-side minus adaptive-side variables. Using three aggregate empirical phases drawn from the McLean and Pontiff-style return decay structure (in-sample discovery, out-of-sample pre-publication, and post-publication), this proof-of-concept validation employs descriptive statistics, correlation analysis, linear regression, logistic classification, feature importance, and cluster interpretation. Results indicate that a higher System Shift Risk Score is associated with higher total return decay, with Chokepoint Severity showing a particularly strong relationship with both total and post-publication decay. Position Quality and Strategy Quality behave as protective variables, while Feedback Maturity requires conceptual refinement as it appears to capture external market learning rather than internal adaptive capability. The study concludes that return predictability decay should be interpreted not only as a statistical or publication phenomenon but also as a system transition in which visibility, imitation, crowding, arbitrage pressure, and adaptive feedback jointly transform the profitability of trading strategies. The contribution lies in formalizing a systems-based explanatory architecture that can be scaled to anomaly-level datasets.
Transformation of Patent Policy in Indonesia: New Opportunities and Challenges for Pharmaceutical Innovation in the Digital Era Raymond R. Tjandrawinata; Henry Soelistyo Budi
Interdiciplinary Journal and Hummanity (INJURITY) Vol. 4 No. 3 (2025): INJURITY: Journal of Interdisciplinary Studies.
Publisher : Pusat Publikasi Nusantara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58631/injurity.v4i3.1415

Abstract

Indonesia is a developing country with an expanding healthcare market, which faces the enduring challenge of fostering a pharmaceutical patent system that incentivizes research and development while ensuring broad access to affordable medicines. This study aims to offer policy recommendations that balance the need for pharmaceutical innovation with the imperative of maintaining an accessible and competitive healthcare landscape. The study includes a review of pharmaceutical patent regulations in India, Brazil, the United States, and the European Union. It integrates empirical data analysis to assess patent application trends and market dynamics, utilizing a difference-in-differences econometric model to establish causality between policy reforms and sector changes. It highlights the necessity of public health safeguards, proposing mechanisms like conditional compulsory licensing as critical elements in the patent reform framework. The study emphasizes actionable policy recommendations while incorporating stakeholder perspectives from regulatory authorities, pharmaceutical firms, and public health organizations to understand the implications for investment, competition, and medicine accessibility. By implementing these strategic policy adjustments, Indonesia can maximize the benefits of Law No. 65 of 2024 while safeguarding public health and promoting domestic pharmaceutical innovation in a rapidly evolving global landscape.
System Shift Risk, Human Capital, and Organizational Culture: A Proxy-Based Exploratory Validation with Methodological Safeguards Raymond Rubianto Tjandrawinata
Interdiciplinary Journal and Hummanity (INJURITY) Vol. 5 No. 6 (2026): Injurity: Interdiciplinary Journal and Humanity
Publisher : Pusat Publikasi Nusantara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58631/injurity.v5i6.1544

Abstract

This study examines whether the System Shift Framework can explain variation in organizational culture, human capital readiness, and resistance to adaptive change. Using a proxy-based firm-level dataset of 889 organizations, the analysis operationalizes seven System Shift dimensions: System Condition (SC), Domain Lock (DL), Actor Complexity (AC), Chokepoint Pressure (CP), Position Quality (POS), Strategy Quality (STR), and Feedback Maturity (FB). The composite risk index is calculated as SC + DL + AC + CP ? POS ? STR ? FB, where higher values indicate stronger cultural and systemic resistance to adaptive transformation. The analysis evaluates associations with Culture Effectiveness, Norms Alignment, Values-Norms Gap, Innovation Performance, Productivity Performance, Compliance and Ethics Performance, and System Shift Success. Results show that the System Shift Risk Score is strongly and negatively associated with Culture Effectiveness (r ? ?0.920), Norms Alignment (r ? ?0.979), and Compliance and Ethics Performance (r ? ?0.761). Regression models explain substantial variance in culture-proximal outcomes, particularly Norms Alignment and Compliance and Ethics Performance, while explanatory power is more modest for innovation and productivity outcomes. Classification analysis shows that logistic regression provides more stable discrimination than random forest under conditions of strong class imbalance, with approximately 2.6% of firms classified as System Shift Success cases. Random forest feature importance identifies Strategy Quality as the dominant predictor of System Shift Success, followed by chokepoint pressure, internal position, and system condition. Cluster analysis identifies three interpretable states: shift-ready and adaptive culture, transitional and mixed condition, and high-risk and resistant culture.
System Shift Risk, Chokepoint Severity, and Macroeconomic Resilience: Quarter-Level Exploratory Evidence from A Configuration-Based Framework Raymond Rubianto Tjandrawinata
Jurnal Ekonomi, Teknologi dan Bisnis Vol. 5 No. 6 (2026): Jurnal Ekonomi, Teknologi dan Bisnis
Publisher : Al-Makki Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.57185/be88z728

Abstract

This study develops and evaluates the System Shift Economics framework as a configuration-based approach for diagnosing macroeconomic vulnerability and adaptive resilience. The framework proposes that forward-looking macroeconomic outcomes are shaped not only by current status categories, but by the interaction between structural pressure and adaptive capacity. Using 203 quarter-level macroeconomic observations — with forward-looking outcomes available for 199 observations — the study constructs a System Shift Risk Score from seven coded variables: System Condition, Domain Lock, Actor Complexity, Chokepoint Severity, Position Quality, Strategy Quality, and Feedback Maturity. The primary outcomes assessed are four-quarter-ahead GDP loss, crisis status, progression toward adaptive recovery, and overall success. The results provide exploratory support for the framework. Chokepoint Severity significantly predicts both four-quarter-ahead GDP loss and crisis probability. Strategy Quality and Feedback Maturity significantly predict Success and Progression in logistic models. The System Shift Risk Score outperforms the baseline status classification across all outcomes, improving explanatory power for GDP loss and discriminatory performance for crisis, success, and progression. Random Forest feature importance analysis identifies the composite risk score and Feedback Maturity as consistently relevant predictors. Cluster analysis further reveals three theoretically coherent regimes: Adaptive/low-risk, Transitional/medium-risk, and Stagnant/high-risk. The findings suggest that macroeconomic resilience is better understood as a system configuration rather than a static status condition. As the framework is newly operationalised, the evidence should be interpreted as exploratory rather than confirmatory; future validation will require independent samples, robustness checks, and external forecasting benchmarks.
Analysis of State Responsibility for Health Rights in Indonesia: Integrating Legal Positivism and Justice Theory Raymond R. Tjandrawinata; Ina Heliany
Eduvest - Journal of Universal Studies Vol. 5 No. 12 (2025): Eduvest - Journal of Universal Studies
Publisher : Green Publisher Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59188/eduvest.v5i12.52613

Abstract

This research examines the legal and moral dimensions of the state's responsibility for the right to health in Indonesia by synthesizing legal positivism and contemporary theories of justice. Focusing on Law No. 17 of 2023 on Health and the National Health Insurance scheme (Jaminan Kesehatan Nasional, JKN), the research argues that formal legal validity alone is insufficient to discharge the state’s constitutional obligations. While Indonesia has constructed a procedurally coherent health law framework that satisfies positivist criteria of legality, significant gaps remain in the realization of substantive justice, particularly for disadvantaged populations. By juxtaposing H.L.A. Hart’s conception of legal validity with John Rawls’s theory of justice as fairness, this study demonstrates that the legitimacy of health law must be assessed not only by its formal pedigree but also by its distributive consequences. The research concludes that state responsibility for health rights requires an integrated approach in which legal positivism is complemented—and normatively corrected—by justice-based evaluation, thereby proposing a dual-threshold conception of state responsibility in health law that distinguishes legal validity from normative legitimacy through doctrinal analysis and normative institutional evaluation. This study conceptually reframes state responsibility for social rights as a dual-threshold structure in which formal legality constitutes a necessary condition of obligation, while distributive justice operates as an independent condition of legitimacy.
System Shift Risk, Measurement Error, and the Limits of Non-Experimental Marketing Measurement: An Exploratory Validation Using RCT Benchmarks Raymond Rubianto Tjandrawinata
Journal Research of Social Science, Economics, and Management Vol. 5 No. 12 (2026): Journal Research of Social Science, Economics, and Management
Publisher : Publikasi Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59141/jrssem.v5i12.1525

Abstract

The increasing complexity of digital advertising environments has created significant challenges in ensuring the accuracy and reliability of marketing measurement. Although randomized controlled trials (RCTs) are considered the benchmark for causal evaluation, their implementation is often constrained by cost, operational limitations, and managerial requirements, leading organizations to rely on non-experimental measurement approaches that may generate substantial estimation errors. This study aims to explore the role of system-level factors in explaining measurement error and to validate the System Shift Framework as a diagnostic approach for understanding the reliability of non-experimental marketing measurement. This research employs an exploratory quantitative design using six aggregate-coded marketing cases and compares non-experimental lift estimates with RCT benchmarks. Data analysis was conducted using descriptive statistics, correlation analysis, linear regression, regularized logistic regression, model comparison, and cluster analysis. The findings indicate that Strategy Quality and Feedback Maturity demonstrate the strongest associations with lower measurement error, higher accuracy, and improved measurement reliability, whereas the aggregate System Shift Risk Score shows limited explanatory power for continuous measurement error. The results suggest that measurement reliability is influenced not only by statistical methods but also by an organization’s capability to interpret, evaluate, and correct analytical outcomes. This study concludes that the System Shift Framework provides a complementary diagnostic perspective for improving marketing measurement practices by integrating causal inference with systems thinking.
The Structured Innovation System: Optimizing Patent Filing and Obtaining Global Protection Raymond R. Tjandrawinata; Henry Soelistyo Budi; Ina Heliany
Journal of Social Science Vol. 6 No. 3 (2025): Journal of Social Science
Publisher : Syntax Corporation Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Innovation is a fundamental driver of economic growth and technological advancement, yet securing intellectual property rights remains a complex challenge. The structured approach to innovation emphasizes key pathways for patent filing and global protection, ensuring a streamlined transition from ideation to commercialization. Drawing from Structured Innovation framework and other theoretical perspectives, this study examines how systematic innovation processes, strategic decision-making, and collaborative ecosystems contribute to robust intellectual property strategies. Through a comparative analysis of legal frameworks, case studies, and empirical data, this study presents insights for inventors and organizations seeking to optimize their patent portfolios. The findings underscore the importance of integrating structured methodologies with legal foresight to enhance global competitiveness and innovation sustainability. Future research directions include the application of structured patent filing to emerging fields such as AI-driven biotechnology and blockchain-based intellectual property management.
Co-Authors . Anindyajati Achmad K. Harzif Agung Endro Nugroho Agung Endro Nugroho Andon Hestiantoro Andreas Bernadinus Atawolo Andri Prasetiyo Anindini Winda Amalia Anita Artarini Armini Syamsidi ARTARINI, ANITA Babu, Murali Mohan Budi Wiweko Caroline G. Puspita CATUR RIANI Citra Rosyidah Danang Agung Yunaidi Dayana, Hepy Debbie S. Retnoningrum Debbie S. Retroningrum DEBBIE SOEFIE RETNONINGRUM DERMAWAN, DONI Dewi Riskha Nurmalasari Diana Nur Afifah Esti Mumpuni Esti Mumpuni Esti, Esti Gayatri, Anggi Gita Pratama Hapsari, Riani Harry Martha Wijaya Hartati Tuna, Hartati Hee Jae Lee Heliany, Ina Henry Soelistyo Budi Henry Soelistyo Budi Henry Soelistyo Budi Henry Soelistyo Budi Henry Soelistyo Budi Henry Soelistyo Budi, Henry Soelistyo Herbert Situmorang Herbert Situmorang Hiendrawan, Stevanus Huda Shalahudin Darusman Ina Heliany Ina Heliany Ina Heliany Ina Heliany Ina Heliany Indriawati, Iin Irsan Hasan Ismaya, Wangsa T. Kaka Renaldi Kanadi Sumapradja Krisnayanti, Ni Putu Eka Kristiana, Hery Kristiana, Hery Laurentia Stephani Liana W. Susanto Lilik Sulastri Luh Putu Nurshanti, Ni Maggy T. Suhartono Maggy T. Suhartono Maggy Thenawidjaja Suhartono Marcellus Simadibrata K Martha Wijaya, Harry Melva Louisa Murali Mohan Babu Murdani Abdullah Nababan, Saut Horas Hatoguan Nafrialdi Nafrialdi Nailufar, Florensia Nailufar, Florensia Ni Luh Putu Nurshanti Novia Tri Astuti Novia Tri Astuti Novitasari, Putri Rachma Permanasari, Silmi Citra Prasetyo, Teguh Rachman, Andika Raden Muharam Natadisastra Retroningrum, Debbie S. Riani Hapsari Santi Tan Setiabudy, Rahajuningsih D Shirly Kumala SILMI MARIYA Simatupang, Stefeny Theresia Sinaga, Wenny S.L. Soelistyo Budi, Henry Steven Susanto, Liana W Suwijiyo Pramono Suwijiyo Pramono Tan, Santi Velliana Tanaya Viedya Novalinda Said Wahyunia Likhayati Septiana Wangsa T. Ismaya Wangsa Tirta Ismaya Wawaimuli Arozal Widjaja, Nadia Winoto, Imelda L Winoto, Imelda L Yanti, Yanti Zaelani, Bella Fatima Dora